These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5061165)

  • 1. Studies in the aromatization of a synthetic progestin.
    Fotherby K; James F; Atkinson L; Dumasia M
    J Endocrinol; 1972 Jan; 52(1):v-vi. PubMed ID: 5061165
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenolic metabolites of DL-norgestrel: a method for the removal of 1-hydroxylated metabolites, potential sources of phenolic artifacts.
    Sisenwine SF; Liu AL; Kimmel HB; Ruelius HW
    Acta Endocrinol (Copenh); 1974 Aug; 76(4):789-800. PubMed ID: 4210574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 5. [The metabolism of norethisterone (17 -ethinyl-4-estren-17 -ol-3-one) and of DL- and D-norgestrel (18-methyl-17 -ethinyl-4-estren-17 -ol-3-one) in man. (Alkyl-substituted steroids. 8)].
    Gerhards E; Hecker W; Hitze H; Nieuweboer B; Bellmann O
    Acta Endocrinol (Copenh); 1971 Oct; 68(2):219-48. PubMed ID: 5171464
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials of a norgestrel-ethinyl estradiol combination sold under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    J Sci Med Lille; 1971; 89(8):333-48. PubMed ID: 5119462
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

  • 9. Gas chromatography of oral progestagens and estrogens.
    Prous JR; Sussmann AR
    Med Actual; 1968; 4(2):56-7. PubMed ID: 12334354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy associated with a combined oral contraceptive and itraconazole.
    Pillans PI; Sparrow MJ
    N Z Med J; 1993 Oct; 106(965):436. PubMed ID: 8414287
    [No Abstract]   [Full Text] [Related]  

  • 11. Interrelationship between oral contraceptives and some parameters of the coagulative-fibrinolytic function (author's transl).
    Chieffi O; Brogioni M; Saltarelli O; Pecchioli S; Benardi M
    Patol Clin Ostet Ginecol; 1981; 9(2):164-72. PubMed ID: 12278647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative clinical and morphological studies of 2 oral contraceptives containing DL-norgestrel or D-norgestre].
    Brosens I; Van Assche A; Wijnants P
    Geburtshilfe Frauenheilkd; 1971 Mar; 31(3):251-7. PubMed ID: 5550233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paget-Schroetter syndrome caused by the use of oral contraceptives].
    Steiner A; Millei J; Ján H; Erös L
    Orv Hetil; 1982 Sep; 123(39):2419-21. PubMed ID: 7145407
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Norgestrel and ethinyl estradiol. New oral agent of controlled dosage for regulating fertility].
    Rice-Wray E; Avila C; Gutiérrez J
    Rev Colomb Obstet Ginecol; 1969; 20(2):61-8. PubMed ID: 5803940
    [No Abstract]   [Full Text] [Related]  

  • 18. [Massive, painful hepatomegaly, sinusoidal dilatation and prolonged use of estroprogestational agents].
    Fischer D; Kémény F; Rauturseau J; Marty M; Karsenti P
    Gastroenterol Clin Biol; 1982 Mar; 6(3):302-4. PubMed ID: 7095347
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of an oral contraceptive on serum phosphohexose isomerase activity.
    Gupta U; Khuteta KP; Gupta RC
    Indian J Physiol Pharmacol; 1983; 27(3):253-4. PubMed ID: 6668056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives].
    Otero González A; Santos C; Jiménez JL; Gil J; Sánchez-Guisande D; Temes Montes XL
    Med Clin (Barc); 1984 May; 82(18):824. PubMed ID: 6429463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.